Use of ranolazine for the preparation of a medicament for the treatment of arrhythmias

Details for Australian Patent Application No. 2011202135 (hide)

Owner Gilead Palo Alto, Inc.

Inventors Belardinelli, Luiz; Antzelevitch, Charles; Blackburn, Brent

Agent Freehills

Pub. Number AU-A-2011202135

Parent 2009201065

Filing date 9 May 2011

Wipo publication date 26 May 2011

International Classifications

C07D 241/04 (2006.01) Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings

A61K 31/495 (2006.01) - having six-membered rings with two nitrogen atoms as the only ring hetero atoms, e.g. piperazine

A61P 9/06 (2006.01) Drugs for disorders of the cardiovascular system

Event Publications

26 May 2011 Application Open to Public Inspection

  Published as AU-A-2011202135

26 May 2011 Complete Application Filed

2 February 2012 Assignment before Grant

  Gilead Palo Alto, Inc. The application has been assigned to Gilead Sciences Inc.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011202136-Improved process for the production of a radioactive aerosol

2011202134-Thread-tapping concrete screw